Amryt Pharma Share Discussion Threads

[richpassi] 06/8/2021 16:35

They did the same in WW2 Pap Hopefully they will eventually join in this time ;) I bought more too , for my sins :)

[papillon] 06/8/2021 16:28

Yes, Adw198, AMYT is an Irish company whose main listing is on Nasdaq. AIM is just the secondary listing and has been since the Aegerion RTO.

Yes, richpassi, there is no doubt the AMYT share price would be a lot higher without the Nasdaq listing. For some reason the Yanks are not enamoured with AMYT.

[richpassi] 06/8/2021 15:49

I feel we would be considerably over £3 if it was for listing on Nasdaq !!! I'll wait .....and really tempted to buy more ?

[adw198] 06/8/2021 15:44

Another revenue upgrade but as feared that doesn’t seem to be what the markets see as most significant.

Think we’re in the hands of the Americans now, but I remain very sold on the business .

Welcome back Pap!

[sidam] 06/8/2021 14:39

No real excitement generated from the presentation which as usual was competent and informative. It now looks as though we must wait until mid September to get to know more about the story. But there does look that is room for a decent recovery in the share price before the huge longer term potential is spelt out in more detail.

[papillon] 06/8/2021 13:08

Pre market price on Nasdaq is higher than yesterday's closing price. Around $10.33.
Just bought a 1000 AMYT @ around 155p.

[bazworth] 06/8/2021 12:34

Don’t think we could ask for more, well done AMRYT!

[paleje] 06/8/2021 12:16

And outlook with more to come.

[waterloo01] 06/8/2021 12:08

Excellent results

[papillon] 05/8/2021 22:23

Yes, Adw198, for whatever reason the price of an ADS at the close on Nasdaq was only $9.63, down 5.5% on the day. Volume was a massive 640,685 ADS's (equivalent to over 3.2m AMYT shares). You could be correct, Adw198 and it could be the final sell off and the shares could rise after noon tomorrow when the results are announced, but who knows for certain? Only insiders and I'm not one of them!

PS Was it in April that the Chairman, Ray Stafford, bought a shed load of AMYT shares at £2?

[adw198] 05/8/2021 21:02

Brutal late crash on Nasdaq there! £1.37 now. I honestly don’t think it’s indicative of results - last time they upgraded revenues and it still dropped because of the deal. But who knows?!

[adw198] 05/8/2021 20:09

Yes, definitely unsettling. Part of the reason I went in again earlier is the Nasdaq price was looking better, albeit briefly. My (uneducated) guess is the slump is down to the arb between the 2 companies, which should soon be over.

Looking forward to seeing the Q2 result tomorrow whatever they bring. Based on FY projections we should presumably be looking at about 50mill revenue for Q2. Be interesting if any Chiasma rev is given.

Exciting day ahead!

[papillon] 05/8/2021 19:56

ADS price down to $9.88 on Nasdaq on massive volume. Why? I was tempted to ignore my charts and have a punt on AMYT, Adw198, today, but the ADS performance this afternoon has made me change my mind. Such a drop in the ADS's and hence sp, just before apparently good results are to be announced, is very unusual in my experience. There surely must be a reason for the falling ADS price.

[adw198] 05/8/2021 18:03

I enjoy your posts Pap, I’m a novice and would always rather hear a counter / balanced view rather than a board full of cheerleaders.


I find the share price pretty baffling given its lower than the phase 3 trial results which should pave the way for a re-rate but like you say it’s probably down to the (US) perception of the Chiasma deal.

I went in again at 1.51 today. I don’t really agree with the concept of averaging down, I try to objectively think where my next batch of money is best off and I think this is going to spring off these levels. I really like the business so intend and trading the short term dips and roses whilst keeping a core holding.

[papillon] 05/8/2021 17:35

The trouble, Adw198, is I'm completely ignorant when it comes to biotechnology and AMYT, so I'm dependent on others, via the chart (specifically the Ichimoku chart), on whether to buy, sell, or hold AMYT shares. Of course seeing the big drop in the ADS Nasdaq pre market quote price made me sell back on 5th May. That was sheer luck on my part and not due to any chart. Sometimes you can get lucky.

[papillon] 05/8/2021 17:16

Currently 10.03 per ADS on Nasdaq on large volume. That price equates to around 145p per AMYT share.

[sidam] 05/8/2021 17:08

Let’s hope that tomorrow’s presentation gives some indications of management’s aspiration for the future now that the acquisition has been completed. The numbers in the SEC filing of the potential were of a size that could justify a share price at a multiple of current levels.

[cwa1] 04/8/2021 15:53

Taken a small punt at about 149 in the hope it is a bit oversold and that the 7/8 announcement is slightly more upbeat than the share price is suggesting. Fingers crossed

[papillon] 04/8/2021 15:11

Latest price for an ADS on Nasdaq is under $10 at 9.88. What is going on? I'd have expected the price to go up in anticipation of the results due on the 7th, not down!
Fortunately I have no AMYT shares, but I do have 15k CVR's, so I still have skin in the game, so to speak.

[albundi1] 29/7/2021 10:00

Adw, paps is full of it. He times his posts to make himself look smart to others on the hope of getting a following. The fact he decides to tell everyone on here now that he has sold whilst amryt in on a downward trend.... His posts should not be taken seriously at all. Give it a bit of time, if amryt is back on an upward trend he will post on here stating he brought "few days ago" again trying to imply he timed in perfectly. His posts amuse me and thats all.

Adw, you are spot on in your observation of him. At a guess the majority on here probably cringe every time they read his posts

ohh and he has filtered me so wont be reading my posts, aint that right PAPS :-)

[adw198] 29/7/2021 08:30

Thanks, mostly makes sense. I find some of yours posts in July a bit odd in terms of how quickly you changed your mind from wanting top ups to telling others they were right to sell but I suppose a week is a long time in politics and especially on the AIM! Sounds like you left mid July around the time you posted about another fall on NASDAQ.

I agree the debt is perhaps a concern and though I’m from an expert they did seem to “pay” a lot for Chiasma, altho obviously there’s significant growth there. The (hopefully) pending FDA approval and associated voucher is what will really open this up - that’s certainly my expectation. Q2 results next week might also spark a revival.

[papillon] 29/7/2021 01:51

Actually Adw198 both the LSE & Nasdaq AMYT charts went bearish in May when the falling 50 day EMA went below the already falling 200 day EMA. A so called "Death Cross". I'd already sold all my AMYT shares before that happened. I sold on the day (5th May?) when AMYT announced that takeover. I sold because I looked at the pre market quote for AMYT on Nasdaq and it had dropped like a stone, so I didn't sell because of any charts!!

I bought back into AMYT in June because the AMYT Ichimoku chart turned weakly bullish (not strongly bullish). Why? Because I believe in AMYT having held them for years, since FAST relisted as AMYT in May 2016, through thick and thin. You could say my heart overruled my head However that Ichimoku chart soon turned strongly bearish again and I sold all the AMYT shares, I had only recently bought, at a loss and invested the proceeds elsewhere. With the benefit of hindsight it was the correct thing to do. This time my head overruled my heart.

Unfortunately the 200 day EMA is still falling as is the 50 day EMA, which has stayed below the 200 day EMA ever since that Bearish Death Cross appeared on the chart.

Why did the Nasdaq investors react so badly to that takeover, when the AIM investors had initially pushed up the share price when the deal was announced at noon and before Nasdaq opened? I've no idea, Adw198. Unfortunately AMYT's primary listing is now on Nasdaq and not on AIM these days. AMYT is an Irish company and at least 70% of the AMYT shares are held as ADS's on Nasdaq. Yankee investors call the tune and they obviously didn't like the news of the acquisition. Did they think AMYT had overpaid? Probably. The company taken over is American so they probably know more about the company than we do.

I'd like to buy AMYT shares again, but it will be because my head says so and not because of my heart. I've lost lots of money in the past falling in love with a share. I'm not about to do it again.

What you do is up to you; you pays your money and you takes your choice. It's your money, just like it's my money. We can spend it how we see fit. At the moment I don't see why I should sell some of my other shares to buy AMYT shares.

[adw198] 28/7/2021 17:48

Hi Pap, I’d previously had a really high opinion of your analysis but this last post mentioning other stocks seems a bit disingenuous. Your posts have always appeared keen (but balanced) on the fundamentals - eg you said when it reaxhed 2.00 you’d buy back again. But here you’re saying some has sold at the right time? Can I ask what changed?

I’m not one for the charts (I’m not clued up enough) but do enjoy the analysis. But likewise you said the charts showed a bullish pattern when it start rising and then when it dropped you said it was bearish, presumably there’s more to it than that. And now you say the rise was actually a dead cat bounce.

Personally I value all analysis but I find some of the above a bit contradictory. Did you drop your entire holding and if not, I’d love to know why not? Cheers

[papillon] 28/7/2021 15:26

You did the right thing, volsung.
God only knows why the AMYT share price rose earlier today as the closing price of an ADS on Nasdaq last night was equivalent to 156p per AMYT share.
I sold my AMYT shares (again) earlier this month which I'd only bought back in June, for a small loss (unfortunately) and put the money into buying extra SQZ and PXC. A wise decision as it has turned out!
There is obviously a reason why American investors don't rate AMYT. Is it the large debt the company has? June's recovery in the share price has all the hallmarks of a "dead cat" bounce, but why? Ray Stafford obviously thought they were cheap at £2, so why do the Yank's not agree?